Design of the SILICOFCM Study: Effect of Sacubitril/Valsartan vs Lifestyle Intervention on Functional Capacity in Patients With Hypertrophic Cardiomyopathy

Clinical Cardiology - United States
doi 10.1002/clc.23346
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Wiley

Related search

Effect of Sacubitril/Valsartan on Natriuresis, Diuresis and Blood Pressure in Hypertensive Patients

Rational Pharmacotherapy in Cardiology
Cardiovascular MedicinePharmacologyCardiology
2017English

Perceived Barriers to Sacubitril/Valsartan Use in Patients With Heart Failure

Journal of Cardiac Failure
Cardiovascular MedicineCardiology
2018English

Sacubitril-Valsartan in Heart Failure and Multimorbidity Patients

ESC heart failure
Cardiovascular MedicineCardiology
2018English

A Review on Comparative Study on the Safety and Effectiveness of Sacubitril-Valsartan Combination With Ace/Arb Therapy in Cardiac Patients

International Journal of Pharmaceutical and Biological Science Archive
2019English

Potential Markers of Sacubitril-Valsartan Tolerance

Journal of Cardiac Failure
Cardiovascular MedicineCardiology
2019English

Effect of Diltiazem on Left Ventricular Isovolumic Relaxation Time in Patients With Hypertrophic Cardiomyopathy.

Japanese Circulation Journal
1983English

A Randomized Study Assessing the Effect of Diet in Cats With Hypertrophic Cardiomyopathy

Journal of Veterinary Internal Medicine
MedicineVeterinary
2014English

Sacubitril/Valsartan Use for the Hospitalist

American Journal of Hospital Medicine
2017English

Safety of Initiation of Sacubitril/Valsartan in ICU Patients With Advanced Decompensated Heart Failure

Journal of Cardiac Failure
Cardiovascular MedicineCardiology
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy